Malignant pleural mesothelioma (MPM) is characterised by late-stage diagnosis and poor
prognosis. Currently, no screening tool is advocated and diagnosis is based on invasive …

Simple Summary Mesothelioma is a cancer of the lining of the lungs caused by breathing in
asbestos fibres. Asbestos was widely used in industry in the last century in most developed …

Since the 2003 guideline, several clinically relevant studies have been published, allowing
new recommendations regarding image guidance of pleural procedures with clear benefits …

Although mesothelioma is the consequence of a protracted immune response to asbestos
fibers and characterized by a clear immune infiltrate, novel immunotherapy approaches …

Symptomatic malignant pleural effusion is a common clinical problem. This condition is
associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies …

Introduction: Pleural effusion is a common clinical problem. Yet, in a significant proportion of
patients (~ 20%), the cause of pleural effusion remains unknown. Understanding the …

Virtually all patients with a newly discovered pleural effusion should undergo thoracentesis
to aid in diagnosis and management. The routine pleural fluid (PF) evaluation usually …

Objective: Medical thoracoscopy is recommended in the investigation of patients with
exudative pleural effusions, especially when pleural fluid analysis is uninformative. The …

Malignant pleural mesothelioma (MPM) is an asbestos-related cancer with a median
survival of 12 months. The MPM incidence is 1–6/100,000 and is increasing as a result of …

Malignancy is one of the most common causes of pleural effusion. Malignant pleural effusion
is defined by the presence of malignant cells in the pleural fluid. Development of malignant …